Prevalence of Thrombosis in COVID-Patients
1 other identifier
observational
525
1 country
1
Brief Summary
Examination of the prevalence of thrombosis in COVID-patients, especially in an out-patient setting. Assessment by duplex sonography. If thrombosis is detected, we will correlate it with immunity status. Assessment of health issues and cognitive function as late complication after infection.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 3, 2020
CompletedFirst Posted
Study publicly available on registry
November 4, 2020
CompletedStudy Start
First participant enrolled
November 4, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2021
CompletedJune 2, 2022
May 1, 2022
8 months
November 3, 2020
May 30, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
prevalence of thrombosis
20 minutes
Secondary Outcomes (2)
correlation to immunity
20 minutes
Assessment of late complications
20 minutes
Study Arms (1)
COVID 19 patients
all patients with positive SARS-CoV 2 swap
Interventions
all patients with consent receive a duplex ultrasound, blood test, cognitive test and test of smelling
Eligibility Criteria
all SARS CoV 2 positive patients registered at local health departments (Augsburg) are invited to join the study
You may qualify if:
- SARS CoV 2 positive swap, at least 4 weeks after infection
You may not qualify if:
- under 18 years old no consent anemia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital Augsburg
Augsburg, 86165, Germany
Related Publications (1)
Schmidbauer L, Kirchberger I, Gosslau Y, Warm TD, Hyhlik-Durr A, Linseisen J, Meisinger C. The association between the number of symptoms and the severity of Post-COVID-Fatigue after SARS-CoV-2 infection treated in an outpatient setting. J Neurol. 2023 Jul;270(7):3294-3302. doi: 10.1007/s00415-023-11752-9. Epub 2023 May 23.
PMID: 37219607DERIVED
Biospecimen
Aliquots for proteomics analysis
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alexander Hyhlik-Duerr, MD
University Hospital Augsburg
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head of department
Study Record Dates
First Submitted
November 3, 2020
First Posted
November 4, 2020
Study Start
November 4, 2020
Primary Completion
June 30, 2021
Study Completion
June 30, 2021
Last Updated
June 2, 2022
Record last verified: 2022-05